GUJTERC
Gujarat Terce Laboratories financials
- Market cap
- ₹28 Cr
Quarterly results
Q2 FY22: revenue up 8.5%, net profit up 178.9% against the same quarter last year.
| Line item | Q1 FY20 | Q2 FY20 | Q3 FY20 | Q4 FY20 | Q1 FY21 | Q2 FY21 | Q1 FY22 | Q2 FY22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 11 | 10 | 9 | 5 −28% | 7 −35% | 10 −2% | 10 +8% |
| EBITDA | -1 | 2 | 0 | -0 | -0 +64% | 0 −94% | 2 +254% | 1 +206% |
| Net profit | -1 | 2 | 0 | -1 | -0 +64% | -0 −101% | 2 +332% | 0 +179% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +2.5% 1Y
1Y: ₹40.01 on 9 Sept 2025 → ₹41. High ₹56.58 (13 Oct 2025), low ₹30.9 (30 Mar 2026).
Financials, as filed
| Year ending | FY20 |
|---|---|
| Revenue | ₹38 Cr |
| Operating profit | ₹1 Cr |
| Operating margin | 1.8% |
| Interest | ₹0 Cr |
| Depreciation | ₹0 Cr |
| Net profit | ₹0 Cr |
| Net margin | 0.7% |
| ROCE | 5.8% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY19 | FY20 | FY21 |
|---|---|---|---|
| Equity capital | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| Reserves | ₹3 Cr | ₹4 Cr | ₹2 Cr |
| Borrowings | ₹1 Cr | ₹2 Cr | ₹4 Cr |
| Other liabilities | ₹8 Cr | ₹9 Cr | ₹11 Cr |
| Total liabilities | ₹19 Cr | ₹22 Cr | ₹25 Cr |
| Fixed assets | ₹2 Cr | ₹2 Cr | ₹4 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹17 Cr | ₹20 Cr | ₹21 Cr |
| Total assets | ₹19 Cr | ₹22 Cr | ₹25 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters added +3.00 pp while the public trimmed −2.98 pp.
- Promoters
- 40.0%
- Public
- 60.0%
Since Jun 2025
- Promoters +3.00 pp
- Public −2.98 pp
How it drifted, 12 quarters
Over this window promoters went from 36.8% to 40.0% — +3.3 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 36.8%, Public 63.2%.Dec '23: Promoters 37.0%, Public 63.0%.Mar '24: Promoters 37.0%, Public 63.0%.Jun '24: Promoters 37.0%, Public 63.0%.Sep '24: Promoters 37.0%, Public 63.0%.Dec '24: Promoters 37.0%, Public 63.0%.Mar '25: Promoters 37.0%, Public 63.0%.Jun '25: Promoters 37.0%, Public 63.0%.Sep '25: Promoters 37.0%, Public 63.0%.Dec '25: Promoters 40.0%, Public 60.0%.Mar '26: Promoters 40.0%, Public 60.0%.Jun '26: Promoters 40.0%, Public 60.0%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Rishabh Negi newly disclosed 1.01% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Gujarat Terce Laboratories Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Aalap Natubhai Prajapati | 17.35% | unchanged |
| Abundant Trade Link Private Limited | 13.81% | unchanged |
| Natwarbhai Parsottam Prajapati | 8.16% | unchanged |
| Sagar Saxena | 1.35% | unchanged |
| Ganesh Vetrivel Periasamy | 1.25% | unchanged |
| Dheeraj Kumar Lohia | 1.04% | unchanged |
| Rishabh Negi | 1.01% | newly disclosed |
| Amritbhai P. Prajapati | 0.40% | unchanged |
| Shobhanaben Natvarbhai Prajapati | 0.21% | unchanged |
| Shachi Ravi Oza | 0.10% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Gujarat Terce Laboratories Ltd
Guides on how to read this kind of business and the numbers that matter.